Advances in AI Platform Provide an Ability to Rapidly Predict, Identify and Design Biomolecular Structures to Accelerate the Pace and Reduce the Cost of...
Investment underscores Aizon’s leadership position in AI-enhanced pharmaceutical manufacturing and will accelerate growth and launch of next-generation eBR
Aizon, an Artificial Intelligence (AI) SaaS provider...
o integrate diverse data in decentralized clinical trials and offer enhanced multi-site, multi-lingual integrations
ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding...
Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced positive preclinical data of its lung fibrosis candidate. This drug operates through a...
Standard BioTools Inc., driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – announced a collaboration agreement with Navignostics...
Multicenter EXCYTE-2 Study to Evaluate the Precision Medicine Platform in Patients With Acute Myeloid Leukemia
Exscientia plc announced the launch of EXCYTE-2, an observational clinical...